Kanvas Biosciences (Seed)

Funding Details
Awarder
Inbox
Date Award
July 01, 2024
Vertical
Biotech
Funding URL
View Funding Page

Company Info
Founding Year
2020
Founders
Matt Cheng, Hao Shi
Company Description
Kanvas Biosciences aims to offer safer and more effective cancer treatments by deploying microorganisms discovered with its novel spatial biology platform. The company's technology explores specific interactions between bacteria and immune cells in a patient's microbiome to enhance cancer treatments.
Market
Healthcare
Location
US
Coinvestors
DCVC, Lions Capital

Links
Back to Home Back to Biotech Deals View Funding Announcement